Prospective, Randomized, Single Center, Open Label Study Designed to Evaluate the Effect on Platelet Reactivity in Response to High Doses of Atorvastatin or Rosuvastatin Administered Before Percutaneous Coronary Intervention (PCI)

Trial Profile

Prospective, Randomized, Single Center, Open Label Study Designed to Evaluate the Effect on Platelet Reactivity in Response to High Doses of Atorvastatin or Rosuvastatin Administered Before Percutaneous Coronary Intervention (PCI)

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs Rosuvastatin (Primary) ; Atorvastatin
  • Indications Coronary disorders; Platelet dysfunction
  • Focus Pharmacodynamics
  • Acronyms STATIPLAT
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 19 Apr 2017 Results assessing acute effect of stanins on platelet reactivity in CSA patients and results of subgroup analysis (chronic low dose statin and statin naive), published in the Clinical Cardiology
    • 05 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top